Perspective Therapeutics, Inc. (CATX)
3.77
-0.11
(-2.84%)
USD |
NYAM |
May 12, 16:00
3.85
+0.08
(+2.12%)
Pre-Market: 09:10
Perspective Therapeutics Cash from Investing (Quarterly) : -109.55M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.077M |
| AVITA Medical, Inc. | -0.019M |
| Twist Bioscience Corp. | -12.71M |
| Elutia, Inc. | 79.58M |
| TriSalus Life Sciences, Inc. | -0.041M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.47M |
| Cash from Financing (Quarterly) | 164.36M |
| Free Cash Flow | -107.53M |
| Free Cash Flow Per Share (Quarterly) | -0.3699 |
| Free Cash Flow to Equity (Quarterly) | -39.30M |
| Free Cash Flow to Firm (Quarterly) | -38.22M |
| Free Cash Flow Yield | -34.95% |